Measurement and Correlation of the Solubility of Telmisartan (Form A) in Nine Different Solvents from 277.85 to 338.35 K
- 368 Downloads
The solubility of telmisartan (form A) in nine organic solvents (chloroform, dichloromethane, ethanol, toluene, benzene, 2-propanol, ethyl acetate, methanol and acetone) was determined by a laser monitoring technique at temperatures from 277.85 to 338.35 K. The solubility of telmisartan (form A) in all of the nine solvents increased with temperature as did the rates at which the solubility increased except in chloroform and dichloromethane. The mole fraction solubility in chloroform is higher than that in dichloromethane, which are both one order of magnitude higher than those in the other seven solvents at the experimental temperatures. The solubility data were correlated with the modified Apelblat equation and λh equations. The results show that the λh equation is in better agreement with the experimental data than the Apelblat equation. The relative root mean square deviations (σ) of the λh equation are in the range from 0.004 to 0.45 %. The dissolution enthalpies, entropies and Gibbs energies of telmisartan in these solvents were estimated by the Van’t Hoff equation and the Gibbs equation. The melting point and the fusion enthalpy of telmisartan were determined by differential scanning calorimetry.
KeywordsTelmisartan Solubility Apelblat equation λh equation Solution thermodynamic properties
The authors would like to thank the National Nature and Science Foundation of China (NSFC, No. 21206032), the Science Foundation Henan University of Technology (No. 2012CXRC08) and the Science Foundation of Henan Province (No. 2015GGJS-039) for their financial assistance for this project. Thanks for David Kearns for the language revision.
- 1.Patel, P.A., Patravale, V.B.: Commercial telmisartan tablets: a comparative evaluation with innovator brand micardis. Int. J. Pharm. Sci. Res. 1, 282–292 (2010)Google Scholar
- 2.Laragh, J.: The renin system and the renal regulation of blood pressure. In: Seldin, D.W., Giebisch, G. (eds.) The Kidney: Physiology and Pathophiyology, 2nd edn, pp. 1411–1453. Raven Press, New York (1992)Google Scholar
- 3.Lepek, P., Sawicki, W., Wlodarski, K., Wojnarowska, Z., Paluch, M., Guzik, L.: Effect of amorphization method on telmisartan solubility and the tableting process. Eur. J. Biochem. 83, 114–121 (2013)Google Scholar
- 5.Adin, I., Iustain, C., Brand, M., Salman, A., Weisman, A.: Processes of Preparing Highly Pure Telmisartan Form A, Suitable for Pharmaceutical Compositions. US Patent 20060276525 (2006)Google Scholar
- 6.Donsbach, K., Hof, I.: Crystalline Form of Telmisartan Sodium. US Patent 6737432 (2004)Google Scholar
- 7.Chen, Y.: Study on quality control and stability test for telmisartan. Master’s thesis, Zhejiang University (2005)Google Scholar
- 9.Nývlt, J.: Solid–Liquid Phase Equilibria. Academia Publishing House of the Czechoslovak Academy of Sciences, Prague (1977)Google Scholar
- 21.Hefter, G.T., Tomkins, R.P.T.: Chapter 1.1. Thermodynamics of Solubility. Wiley, New York (2004)Google Scholar
- 25.El-Bindary, A.A., El-Sonbati, A.Z., Ahmed, E.M.A.M., El-Bindary, A.A., El-Sonbati, A.Z.: Potentiometric and thermodynamic studies of azosulfonamide drugs. X. Chem. Pap. 57, 255–258 (2003)Google Scholar
- 26.Kapil, B., Shipra, B.: Measurement and correlation for solubility of some pyrimidine derivatives in different solvents. J. Appl. Chem. 2014, 1–7 (2014)Google Scholar